类风湿关节炎中的白蛋白尿:与RA特征及亚临床动脉粥样硬化的关联
在196例RA患者与271例匹配非RA对照中, elevated uACR(女性≥25 mg/gm、男性≥17 mg/gm)比例分别为18%与17%(P=0.89)。校正后RA与uACR升高几率降低57%相关(P=0.016)。RA组中uACR升高与动脉粥样硬化指标及关键心血管代谢危险因素无关联,提示uACR作为RA亚临床CVD指标价值较低。
要点
- RA患者与匹配对照的uACR升高比例无显著差异(18% vs 17%,P=0.89)。
- 校正后RA与uACR升高几率降低57%相关(P=0.016)。
- RA组中uACR升高与动脉粥样硬化指标及心血管代谢危险因素无关联。
核心结论
- RA组中uACR升高与动脉粥样硬化测量指标及若干关键心血管代谢危险因素无关联,提示uACR作为RA亚临床CVD指标 usefulness 较低。
研究设计与样本
- 横断面比较RA患者与人口学匹配的普通人群非RA对照,测量晨尿白蛋白并计算uACR。
主要发现
- 比较了196例RA患者与271例非RA对照,uACR升高(女性≥25 mg/gm、男性≥17 mg/gm)比例分别为18%与17%(P=0.89)。
- 校正后RA与uACR升高几率降低57%相关(P=0.016)。
- 对照组中较高血清肌酐水平与高血压均与uACR升高强烈且显著相关,但RA组无此关联(交互作用P均<0.05)。
- RA患者中接受TNF抑制剂治疗者校正后uACR升高患病率不足未接受者的二分之一(9% vs 20%,P=0.047)。
关键数值与推荐
- uACR升高定义:女性≥25 mg/gm,男性≥17 mg/gm。
临床怎么用
- 在RA患者中,uACR升高不宜单独作为亚临床动脉粥样硬化或心血管代谢风险的指示指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Albuminuria is a marker for subclinical cardiovascular disease (CVD) in the general population. It is uncertain whether this association is present in patients with rheumatoid arthritis (RA), a population with increased atherosclerosis and CVD events. METHODS: Urine albumin from a spot morning collection was measured, and the urine albumin-to-creatinine ratio (uACR) was calculated for RA patients and a population-based sample of demographically matched non-RA controls. Associations of elevated uACR (≥25 mg/gm for women and ≥17 mg/gm for men) with CVD risk factors and measures of atherosclerosis (coronary artery calcification, ultrasound-determined maximal intima-media thickness of the common carotid artery and internal carotid artery [ICA], and the presence of focal plaque in the ICA) were compared cross-sectionally according to RA status. RESULTS: We compared 196 RA patients with 271 non-RA controls. Elevated uACR was found in 18% of the RA patients compared with 17% of the controls (P = 0.89). After adjustment, RA was associated with 57% lower odds of elevated uACR (P = 0.016). Higher serum creatinine levels and hypertension were both strongly and significantly associated with elevated uACR in the control group but not in the RA group (both P for interaction < 0.05). Among RA characteristics, the adjusted prevalence of elevated uACR among those treated with tumor necrosis factor inhibitors was less than half that among those not so treated (9% versus 20%, respectively; P = 0.047). CONCLUSION: There was no association in the RA group of elevated uACR with measures of atherosclerosis or with several key cardiometabolic risk factors, which suggests a lower usefulness of elevated uACR as an indicator of subclinical CVD in RA.
引用
- Sammut A, Shea S, Blumenthal RS, et al. Albuminuria in Rheumatoid Arthritis: Associations With Rheumatoid Arthritis Characteristics and Subclinical Atherosclerosis. Arthritis Care Res (Hoboken). 2017. PMID: 28257609. doi:10.1002/acr.23234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。